Right before her adoption, Piper, a senior Yorkie, suffered liver failure. She was rushed to the ER and is now receiving the ...

Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren ...

There has been a tremendous rise in the number of deaths in Goa due to alcohol-related liver cirrhosis in youngsters, ...

A new approach combining immunotherapy, radiation, and surgery enabled successful liver cancer removal in a high-risk patient ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...